BCL2L1 and Miyoshi myopathy: In contrast to prior observations with Ven monotherapy treatment,13 no significant association between response and baseline BCL2L1 or BCL2:BCL2L1 expression was observed in VenDex treated patients, however higher BCL2 levels were found in patients who achieved a response which is consistent with the mechanism of action in t(11;14) positive MM.